iTeos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ITOS and buy or sell other stocks, ETFs, and their options commission-free!About ITOS
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984.
CEOKevin C. Tang
CEOKevin C. Tang
Employees173
Employees173
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2012
Founded2012
Employees173
Employees173
ITOS Key Statistics
Market cap448.30M
Market cap448.30M
Price-Earnings ratio-2.09
Price-Earnings ratio-2.09
Dividend yield—
Dividend yield—
Average volume1.76M
Average volume1.76M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$17.63
52 Week high$17.63
52 Week low$4.80
52 Week low$4.80
Stock Snapshot
As of today, iTeos Therapeutics(ITOS) shares are valued at $10.15. The company's market cap stands at 448.3M, with a P/E ratio of -2.09.
On 2025-12-12, iTeos Therapeutics(ITOS) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for iTeos Therapeutics(ITOS) stock has reached 0, versus its average volume of 1.76M.
Over the past 52 weeks, iTeos Therapeutics(ITOS) stock has traded between a high of $17.63 and a low of $4.80.
Over the past 52 weeks, iTeos Therapeutics(ITOS) stock has traded between a high of $17.63 and a low of $4.80.
People also own
Based on the portfolios of people who own ITOS. This list is generated using Robinhood data, and it’s not a recommendation.